Abstract

Objective To study the efficacy and safety of hepatic arterial infusion of Endostatin (YH-16, Endostar), combined with transcatheter arterial chemoembolization (TACE) on advanced hepatocellular carcinoma.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call